NIH Director Page NIH Health Information Page NIH Impact NIH Fact Sheets NIH Social Media and Outreach
EurekAlert! - National Institutes of Health  
LINKS

Resources

 

NIH Main

 

NIH Research News

 

Funded News

 
  For News & Research
  NIH Videos
  eColumn: NIH Research Matters
  NIH News in Health
  NIH Fact Sheets
 
  Additional Resources
  NIH Home Page
 

About NIH

  NIH Health Information
  Pub Med
  MedlinePlus
  Clinical trials.gov
  More News and Events Sources
  NIH News and Events, Special Interest
 
  RSS Feed RSS Feed
  Back to EurekAlert!
 

 


Department of Health and Human Services

News from the National Institutes of Health

Funded News


Key: Meeting M      Journal J      Funder F

Showing releases 2876-2900 out of 3459.

<< < 111 | 112 | 113 | 114 | 115 | 116 | 117 | 118 | 119 | 120 > >>

Public Release: 1-Nov-2013
Neuron
Neuroscientists determine how treatment for anxiety disorders silences fear neurons
In a study published in Neuron, Tufts neuroscientists report that exposure therapy, a common treatment for anxiety disorders, remodels an inhibitory junction in the mouse brain. The findings improve the understanding of how exposure therapy suppresses fear responses and may aid in the development of more effective treatments for anxiety disorders.
National Institutes of Health

Contact: Siobhan Gallagher
siobhan.gallagher@tufts.edu
617-636-6586
Tufts University, Health Sciences Campus

Public Release: 1-Nov-2013
Brain, Behavior and Immunity
Children of lower socioeconomic status grow up more susceptible to catching colds, Carnegie Mellon researchers find
Researchers at Carnegie Mellon University have found an association between lower socioeconomic status during childhood and adolescence and the length of telomeres, protective cap-like protein complexes at the end of chromosomes, that ultimately affects the susceptibility to colds in middle-aged adults. Published in Brain, Behavior and Immunity, the study showed that children and teens with parents of lower socioeconomic status have shorter telomeres as adults.
NIH/National Institute of Allergy and Infectious Diseases, NIH/National Center for Complementary and Alternative Medicine

Contact: Shilo Rea
shilo@cmu.edu
412-268-6094
Carnegie Mellon University

Public Release: 1-Nov-2013
Pediatrics
Home visits lessen emergency care for infants
Home visits from a nurse are a proven but expensive way to help newborns get a good start in life. New research from Duke University suggests that less costly home visiting programs can reach more families and still produce significant health care improvements. Infants in the study had 50 percent fewer emergency care episodes than other babies in the first year of life.
NIH/National Institute on Drug Abuse, The Duke Endowment, Pew Center on the States

Contact: Alison Jones
Alison.jones@duke.edu
919-681-8504
Duke University

Public Release: 1-Nov-2013
Journal of Clinical Investigation
Dysfunctional chemokine receptor promotes candidiasis
In this issue of the Journal of Clinical Investigation, Michail Lionakis and colleagues at the National Institute of Allergy and Infectious Diseases demonstrated that the chemokine receptor CX3CR1 is required for the interaction of C. albicans and macrophages in the kidney.
NIH/Division of Intramural Research, NIH/National Institute of Allergy and Infectious Diseases, NIH/Transition Program in Clinical Research

Contact: Corinne Williams
press_releases@the-jci.org
Journal of Clinical Investigation

Public Release: 1-Nov-2013
Journal of Clinical Investigation
JCI early table of contents for Nov. 1, 2013
This release contains summaries, links to PDFs, and contact information for the following newsworthy papers to be published online, Nov. 1, 2013 in the JCI: "Liver tropism is key for B cell deletion immunotherapy," "Dysfunctional chemokine receptor promotes candidiasis," "Retinoblastoma protein prevents enteric nervous system defects and intestinal pseudo-obstruction," "Transmembrane protein ESDN promotes endothelial VEGF signaling and regulates angiogenesis," "Apelin is a positive regulator of ACE2 in failing hearts," and more.
National Institutes of Health, Fonds de la Recherche du Québec-Santé, Knights Templar Eye Foundation, Children's Discovery Institute

Contact: Corinne Williams
press_releases@the-jci.org
Journal of Clinical Investigation

Public Release: 31-Oct-2013
Science
Scientists capture most detailed picture yet of key AIDS protein
Collaborating scientists at the Scripps Research Institute and Weill Cornell Medical College have determined the first atomic-level structure of the tripartite HIV envelope protein -- long considered one of the most difficult targets in structural biology and of great value for medical science.
NIH/National Institute of General Medical Sciences, International AIDS Vaccine Initiative Neutralizing Antibody Consortium

Contact: Sarah Smith
sas2072@med.cornell.edu
646-317-7401
Weill Cornell Medical College

Public Release: 31-Oct-2013
Frontiers in Neurology
Microbleeds important to consider in brain-related treatments, UCI neurologist says
As growing numbers of America's baby boomers reach retirement, neuroscientists are expanding their efforts to understand and treat one of the leading health issues affecting this population: age-related neurological deterioration, including stroke and dementia.
National Institutes of Health

Contact: Tom Vasich
tmvasich@uci.edu
949-824-6455
University of California - Irvine

Public Release: 31-Oct-2013
Frontiers in Psychology
NYU study on incarcerated youth shows potential to lower anti-social behavior and recidivism
It is the first study to show that mindfulness training can be used in combination with cognitive behavioral therapy to protect attentional functioning in high-risk incarcerated youth.
NIH/National Institute on Drug Abuse

Contact: Christopher James
christopher.james@nyu.edu
212-998-6876
New York University

Public Release: 31-Oct-2013
Akron researcher awarded NIH grant for advancing 3-D tumor models for anticancer drug testing
University of Akron assistant professor of biomedical engineering Hossein Tavana was awarded $511,000 from the National Institutes of Health to support his efforts to improve chemotherapeutic drug testing and effectiveness. Tavana has developed a novel method of generating 3-D cultures of cancer cells that better mimic tumors in the body. Tavana calls this the next step toward personalized medicine by which doctors could extract and test patients' cancer cells in vitro to determine the most effective treatment in vivo.
National Institutes of Health

Contact: Denise Henry
henryd@uakron.edu
330-972-6477
University of Akron

Public Release: 31-Oct-2013
PLOS Computational Biology
Automated system promises precise control of medically induced coma
Putting patients with severe head injuries or persistent seizures into a medically induced coma currently requires that a nurse or other health professional constantly monitor the patient's brain activity and manually adjust drug infusion to maintain a deep state of anesthesia. Now a computer-controlled system developed by Massachusetts General Hospital investigators promises to automate the process, making it more precise and efficient and opening the door to more advanced control of anesthesia.
National Institutes of Health

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital

Public Release: 31-Oct-2013
Proceedings of the National Academy of Sciences
Biochemists find incomplete protein digestion is a useful thing for some bacteria
Protein degradation by energy-dependent proteases normally results in the complete destruction of target proteins, Chien notes. However, under particularly harsh artificial conditions in the test tube, these proteases can stall on certain targets. But until the recent UMass Amherst experiments, such an effect had never been seen inside a living bacterial cell, he adds.
NIH/National Institute for General Medical Sciences, University of Massachusetts Amherst

Contact: Janet Lathrop
jlathrop@admin.umass.edu
413-545-0444
University of Massachusetts at Amherst

Public Release: 31-Oct-2013
Journal of Clinical Investigation
Newly identified proteins make promising targets for blocking graft-vs.-host disease
Researchers from the University of Michigan Comprehensive Cancer Center have identified new proteins that control the function of critical immune cell subsets called T-cells, which are responsible for a serious and often deadly side effect of lifesaving bone marrow transplants.
National Institutes of Health, Leukemia Lymphoma Society, American Society of Transplantation

Contact: Nicole Fawcett
nfawcett@umich.edu
734-764-2220
University of Michigan Health System

Public Release: 31-Oct-2013
CWRU researchers aim nanotechnology at micrometastases
Researchers at Case Western Reserve University have received two grants totaling nearly $1.7 million to build nanoparticles that seek and destroy metastases too small to be detected with current technologies. They are targeting aggressive cancers that persist through traditional chemotherapy.
NIH/National Cancer Institute, Ohio Cancer Research Associates

Contact: Kevin Mayhood
kevin.mayhood@case.edu
216-368-4442
Case Western Reserve University

Public Release: 31-Oct-2013
PLOS Genetics
'Flipping the switch' reveals new compounds with antibiotic potential
Researchers have discovered that one gene in a common fungus acts as a master regulator, and deleting it has opened access to a wealth of new compounds that have never before been studied -- with the potential to identify new antibiotics.
National Institutes of Health, American Cancer Society

Contact: Michael Freitag
freitagm@science.oregonstate.edu
541-737-4845
Oregon State University

Public Release: 31-Oct-2013
Science
Gene found to foster synapse formation in the brain
Researchers at Johns Hopkins say they have found that a gene already implicated in human speech disorders and epilepsy is also needed for vocalizations and synapse formation in mice. The finding, they say, adds to scientific understanding of how language develops, as well as the way synapses -- the connections among brain cells that enable us to think -- are formed. A description of their experiments appears in Science Express on Oct. 31.
NIH/National Institute of Mental Health, NIH/National Institute of Neurological Disorders and Stroke

Contact: Shawna Williams
shawna@jhmi.edu
410-955-8236
Johns Hopkins Medicine

Public Release: 31-Oct-2013
Science
Critical gene in retinal development and motion sensing identified
Our vision depends on exquisitely organized layers of cells within the eye's retina, each with a distinct role in perception. Johns Hopkins researchers say they have taken an important step toward understanding how those cells are organized to produce what the brain "sees." Specifically, they report identification of a gene that guides the separation of two types of motion-sensing cells, offering insight into how cellular layering develops in the retina, with possible implications for the brain's cerebral cortex.
NIH/National Institute of Neurological Disorders and Stroke, NIH/National Eye Institute, Human Frontier Science Program

Contact: Shawna Williams
shawna@jhmi.edu
410-955-8236
Johns Hopkins Medicine

Public Release: 31-Oct-2013
Cell
Study offers new theory of cancer development
Researchers have devised a way to understand patterns of aneuploidy -- an abnormal number of chromosomes -- in tumors and predict which genes in the affected chromosomes are likely to be cancer suppressors or promoters. They propose that aneuploidy is a driver of cancer rather than a result of it.
US Department of Defense, National Institutes of Health, Howard Hughes Medical Institute

Contact: David Cameron
david_cameron@hms.harvard.edu
617-432-0441
Harvard Medical School

Public Release: 31-Oct-2013
Science
Scientists capture most detailed picture yet of key AIDS protein
Collaborating scientists at The Scripps Research Institute (TSRI) and Weill Medical College of Cornell University have determined the first atomic-level structure of the tripartite HIV envelope proteinólong considered one of the most difficult targets in structural biology and of great value for medical science.
National Institutes of Health, NIH/National Institute of General Medical Sciences Biomedical Research Technology Program, International AIDS Vaccine Initiative

Contact: Mika Ono
mikaono@scripps.edu
858-784-2052
Scripps Research Institute

Public Release: 30-Oct-2013
NIH awards $1.7 million to neuroscientist for visual perception research
University of California, Riverside neuroscientist Aaron Seitz has been awarded a five-year, $1.7 million grant by the National Institutes of Health to continue groundbreaking research that may lead to new therapies for individuals with amblyopia (lazy eye), dry macular degeneration and cataracts.
National Institutes of Health

Contact: Bettye Miller
bettye.miller@ucr.edu
951-827-7847
University of California - Riverside

Public Release: 30-Oct-2013
Vaccine
HPV vaccination rates alarmingly low among young adult women in South
Initiation and completion rates for the human papillomavirus vaccine series are significantly lower in the South than any other geographic region, according to a new study from researchers at the University of Texas Medical Branch at Galveston. The new findings are especially disconcerting because cervical cancer -- which is caused almost exclusively by HPV -- is more prevalent in the South than in any other region. Further, although vaccination rates have risen since 2008, the findings underscore the need for increased physician recommendation and vaccine assistance programs.
NIH/Eunice Kennedy Shriver National Institute of Child Health and Human Development

Contact: Molly Dannenmaier
mjdannen@utmb.edu
409-772-8790
University of Texas Medical Branch at Galveston

Public Release: 30-Oct-2013
Nature
New SARS-like coronavirus discovered in Chinese horseshoe bats
EcoHealth Alliance, a nonprofit organization that focuses on local conservation and global health issues, announced the discovery of a new SARS-like coronavirus (CoV) in Chinese horseshoe bats.
National Institutes of Health, National Science Foundation

Contact: Anthony M. Ramos
ramos@ecohealthalliance.org
212-380-4469
EcoHealth Alliance

Public Release: 30-Oct-2013
American Journal of Epidemiology
Low vitamin D levels during pregnancy associated with preterm birth in non-white mothers
African-American and Puerto Rican women who have low levels of vitamin D during pregnancy are more likely to go into labor early and give birth to preterm babies, research led by the University of Pittsburgh Graduate School of Public Health reveals. The study, the largest to date to look at the association between vitamin D and preterm birth, is now available online in the American Journal of Epidemiology.
National Institutes of Health

Contact: Allison Hydzik
hydzikam@upmc.edu
412-647-9975
University of Pittsburgh Schools of the Health Sciences

Public Release: 30-Oct-2013
Journal of Cancer Survivorship
Qigong can help fight fatigue in prostate cancer survivors
Flowing movements and meditative exercises of the mind-body activity Qigong may help survivors of prostate cancer to combat fatigue. These are the findings of a study by Dr. Anita Y. Kinney at the University of New Mexico Cancer Center and Dr. Rebecca Campo at the University of North Carolina at Chapel Hill. The study took place at the Huntsman Cancer Institute at the University of Utah, and was published in Springer's Journal of Cancer Survivorship.
NIH/National Center for Complementary and Alternative Medicine, University of Utah/Center on Aging Pilot Award

Contact: Joan Robinson
joan.robinson@springer.com
49-622-148-78130
Springer

Public Release: 30-Oct-2013
PLOS ONE
Gladstone scientists identify molecular signals that rouse dormant HIV infection
Perhaps the single greatest barrier to curbing the spread of HIV/AIDS is the dormant, or "latent," reservoir of virus, which is out of reach of even the most potent medications. But now, scientists at the Gladstone Institutes have uncovered new clues that may help researchers awaken HIV from its slumber -- laying the foundation for purging all trace of the virus, and for one day finding a cure for the more than 34 million people worldwide living with HIV/AIDS.
National Institutes of Health

Contact: Anne Holden
anne.holden@gladstone.ucsf.edu
415-734-2534

Public Release: 30-Oct-2013
Psychological Science
Seeing in the dark
With the help of computerized eye trackers, a new cognitive science study finds that at least 50 percent of people can see the movement of their own hand even in the absence of all light.
National Institutes of Health, Korea Science and Engineering Foundation

Contact: Susan Hagen
susan.hagen@rochester.edu
585-276-4061
University of Rochester

Showing releases 2876-2900 out of 3459.

<< < 111 | 112 | 113 | 114 | 115 | 116 | 117 | 118 | 119 | 120 > >>

     
   

HOME    DISCLAIMER    PRIVACY POLICY    CONTACT US
Copyright ©2014 by AAAS, the science society.